Leerink Partnrs Brokers Lower Earnings Estimates for LXEO
Lexeo Therapeutics, Inc. (NASDAQ:LXEO – Free Report) – Equities researchers at Leerink Partnrs dropped their Q2 2025 earnings per share (EPS) estimates for Lexeo Therapeutics in a research report issued to clients and investors on Monday, May 12th. Leerink Partnrs analyst M. Foroohar now forecasts that the company will post earnings per share of ($0.82) […]
Lexeo Therapeutics, Inc. (NASDAQ:LXEO – Free Report) – Equities researchers at Leerink Partnrs dropped their Q2 2025 earnings per share (EPS) estimates for Lexeo Therapeutics in a research report issued to clients and investors on Monday, May 12th. Leerink Partnrs analyst M. Foroohar now forecasts that the company will post earnings per share of ($0.82) […]
